Vor Biopharma, Inc. (VOR)
22.71
-0.65
(-2.78%)
USD |
NASDAQ |
Aug 24, 16:00
22.71
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Market Cap : 1.237B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.237B |
| August 21, 2026 | 1.272B |
| August 20, 2026 | 1.256B |
| August 19, 2026 | 1.284B |
| August 18, 2026 | 1.268B |
| August 17, 2026 | 1.253B |
| August 14, 2026 | 1.254B |
| August 13, 2026 | 1.268B |
| August 12, 2026 | 1.217B |
| August 11, 2026 | 1.285B |
| August 10, 2026 | 1.273B |
| August 07, 2026 | 1.289B |
| August 06, 2026 | 1.291B |
| August 05, 2026 | 1.207B |
| August 04, 2026 | 1.206B |
| August 03, 2026 | 1.160B |
| July 31, 2026 | 1.146B |
| July 30, 2026 | 1.181B |
| July 29, 2026 | 1.059B |
| July 28, 2026 | 1.084B |
| July 27, 2026 | 1.053B |
| July 24, 2026 | 1.044B |
| July 23, 2026 | 1.028B |
| July 22, 2026 | 1.057B |
| July 21, 2026 | 1.086B |
| Date | Value |
|---|---|
| July 20, 2026 | 945.54M |
| July 17, 2026 | 980.22M |
| July 16, 2026 | 939.58M |
| July 15, 2026 | 979.68M |
| July 14, 2026 | 1.002B |
| July 13, 2026 | 976.97M |
| July 10, 2026 | 1.037B |
| July 09, 2026 | 1.070B |
| July 08, 2026 | 1.101B |
| July 07, 2026 | 1.089B |
| July 06, 2026 | 1.089B |
| July 02, 2026 | 1.116B |
| July 01, 2026 | 996.47M |
| June 30, 2026 | 997.56M |
| June 29, 2026 | 1.008B |
| June 26, 2026 | 872.39M |
| June 25, 2026 | 808.99M |
| June 24, 2026 | 784.61M |
| June 23, 2026 | 804.66M |
| June 22, 2026 | 809.53M |
| June 18, 2026 | 785.15M |
| June 17, 2026 | 813.87M |
| June 16, 2026 | 764.56M |
| June 15, 2026 | 762.39M |
| June 12, 2026 | 778.11M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Dyne Therapeutics, Inc. | 4.306B |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
| Anika Therapeutics, Inc. | 285.59M |
| BioCryst Pharmaceuticals, Inc. | 2.471B |
Market Cap Related Metrics
| Price | 22.71 |
| Earnings Yield | -367.2% |